SBIO
SBIO
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 KYMR | Kymera Therapeutics, Inc. | 3.86% | 64.08K | $4.91M |
 CRNX | Crinetics Pharmaceuticals, Inc. | 3.23% | 76.99K | $4.11M |
 CELC | Celcuity Inc. | 3.22% | 37.52K | $4.10M |
 ALKS | Alkermes plc | 3.09% | 134.03K | $3.93M |
 ACAD | ACADIA Pharmaceuticals Inc. | 2.96% | 137.33K | $3.77M |
 FOLD | Amicus Therapeutics, Inc. | 2.81% | 250.30K | $3.58M |
 APGE | Apogee Therapeutics, Inc. | 2.76% | 44.47K | $3.51M |
 MIRM | Mirum Pharmaceuticals, Inc. | 2.69% | 41.68K | $3.42M |
 GPCR | Structure Therapeutics Inc. | 2.56% | 49.23K | $3.26M |
 NAMS | NewAmsterdam Pharma Company N.V. | 2.56% | 91.97K | $3.26M |
 VKTX | Viking Therapeutics, Inc. | 2.33% | 91.69K | $2.97M |
 CGON | CG Oncology, Inc. Common stock | 2.18% | 65.38K | $2.78M |
 APLS | Apellis Pharmaceuticals, Inc. | 2.14% | 102.66K | $2.72M |
 TARS | Tarsus Pharmaceuticals, Inc. | 2.11% | 34.41K | $2.69M |
 IDYA | IDEAYA Biosciences, Inc. | 2.11% | 71.07K | $2.69M |
 XENE | Xenon Pharmaceuticals Inc. | 2.07% | 62.67K | $2.64M |
 TVTX | Travere Therapeutics, Inc. | 2.07% | 72.53K | $2.63M |
 VERA | Vera Therapeutics, Inc. | 1.98% | 51.87K | $2.52M |
 IRON | Disc Medicine, Inc. | 1.95% | 30.59K | $2.48M |
 NUVB | Nuvation Bio Inc. | 1.93% | 278.09K | $2.46M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Ireland
Canada
Belgium
United Kingdom
Switzerland
China
Germany
Cayman IslandsSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Ireland Canada Belgium United Kingdom Switzerland China Germany Cayman IslandsHoldings (Top 20)
KYMR
Kymera Therapeutics, Inc.
CRNX
Crinetics Pharmaceuticals, Inc.
CELC
Celcuity Inc.
ALKS
Alkermes plc
ACAD
ACADIA Pharmaceuticals Inc.
FOLD
Amicus Therapeutics, Inc.
APGE
Apogee Therapeutics, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
GPCR
Structure Therapeutics Inc.
NAMS
NewAmsterdam Pharma Company N.V.
VKTX
Viking Therapeutics, Inc.
CGON
CG Oncology, Inc. Common stock
APLS
Apellis Pharmaceuticals, Inc.
TARS
Tarsus Pharmaceuticals, Inc.
IDYA
IDEAYA Biosciences, Inc.
XENE
Xenon Pharmaceuticals Inc.
TVTX
Travere Therapeutics, Inc.
VERA
Vera Therapeutics, Inc.
IRON
Disc Medicine, Inc.
NUVB
Nuvation Bio Inc.